Enzyme Plays Dual Role Wednesday, December 09, 2015 UT Southwestern Medical Center and California researchers have provided the first report that an enzyme previously known solely for its role in cell division also acts as an on-off switch in the innate immune system.Immune Cells Make Appendix 'Silent Hero' Of Digestive Health Monday, December 07, 2015 New research shows a network of immune cells helps the appendix play a pivotal role in maintaining digestive health, supporting the theory that the appendix isn’t a redundant organ.Promising New Treatment Joins the War on Superbugs Monday, December 07, 2015 The fight against superbugs has been bolstered thanks to a promising new therapy discovered by University of Adelaide researchers.The Virus-Host Arms Race Monday, December 07, 2015 Not every virus wants to go viral - at least, not immediately. Some want to slip in quietly. Hide. Wait for the perfect opportunity to attack.GSK, Zymeworks Collaborate Friday, December 04, 2015 Focus on the research, development, and commercialization of novel Fc-engineered monoclonal and bi-specific antibody therapeutics which have been optimized for specific therapeutic effects.ViroMed, bluebird bio Partner Friday, December 04, 2015 Exclusive license agreement to research, develop and commercialize chimeric antigen receptor (CAR) T cell therapies using ViroMed’s proprietary humanized antibody to an undisclosed cancer target for solid tumors.The First Line of Immune Defence Thursday, December 03, 2015 New research breaks with existing knowledge about how our immune system works. Embryonic Switch for Cancer Stem Cell Generation Wednesday, December 02, 2015 An international team of scientists report that decreases in a specific group of proteins trigger changes in the cancer microenvironment that accelerate growth and development of therapy-resistant cancer stem cells (CSCs).
Adaptimmune, Universal cells Collaborate Wednesday, December 02, 2015 The companies have announced that they have entered into a collaboration and exclusive license agreement for the development of allogeneic T cell therapies.